Pipeline

Pipeline

Our Pipeline: LB1148

Research

Pre-Clinical

Phase 1

Phase 2

Phase 3

INDICATION

Accelerating Return of Postoperative GI Function

GI Surgery • Phase 3 Study Ongoing
Cardiovascular Surgery • Phase 2 Complete

INDICATION

Prevention of Post-surgical Abdominal Adhesions

GI Surgery • Phase 2 Ongoing (Fast Track Designation)

Commercial rights to LB1148 in Greater China (excluding Taiwan) have been out-licensed to Newsoara